Summary
BioMark Diagnostics
Founded in 2014
Description
Biomark Diagnostics is a leading company in early stage cancer detection. They provide advanced stage diagnostic technology and antibody-based cancer treatment solutions. Their focus is on improving detection, monitoring, and screening for hard-to-dete...
Strengths
- BioMark Diagnostics has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since BioMark Diagnostics was founded, the company has grown faster than the industry average
Annual Revenue
BioMark Diagnostics's annual revenue
$15000
Based on Kona Equity data
-
Revenue per employee
$1250
-
Variance of revenue growth
0.02
-
Annual revenue growth since founding
$1994000
-
Revenue growth rate from first known quarter to current
9.3%
Employee Count
12 employees
-
Employee growth rate from first known quarter to current
9.6%
Executives
Andrew Maksymiuk
Oncologist
a**@biomarkdiagnostics.comAnatole Pelletier
Scientifique Principal, Spectrométrie De Masse
a**@biomarkdiagnostics.comGina Huang
Chief Financial Officer
g**@biomarkdiagnostics.comStephanie Yee
Senior Product Manager, Clinical SME
s**@biomarkdiagnostics.comRashid Bux
Chief Executive Officer
r**@biomarkdiagnostics.comSandra Loo
Product Representative
s**@biomarkdiagnostics.comNeal Kaplan
Chief Financial Officer (US)
n**@biomarkdiagnostics.comMuhammad Awais
Principal Software Engineer
m**@biomarkdiagnostics.comPhone Diagnostics
Chief Executive Officer
p**@biomarkdiagnostics.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Metabolomic Technologies
mtidx.com- Founded in 2010
- Location: Edmonton, Alberta
- Annual Revenue: $4.9M
- Employees: 25
- Metabolomic Technologies Inc. is a company developing metabolomics based in vitro diagnostics for cancer and other diseases. Our lead product is PolypDx, a urine-based screening test for the detection of adenomatous polyps and colorectal cancer. We sp...
Aquila Diagnostics Systems
aquiladiagnostics.com- Founded in 2009
- Location: Edmonton, Alberta
- Annual Revenue: $7.2M
- Employees: 37
- Aquila is a medical device company focused on point-of-care diagnosis testing for blood borne infectious diseases and cancer. The Company is developing a portable diagnostic system that delivers rapid, low-cost, multiparameter tests without the need for highly-skilled operators. Aquila's gel post PCR technology is pro…
ImmunoPrecise Antibodies
immunoprecise.com- Founded in 1989
- Location: Victoria, British Columbia
- Annual Revenue: $14.7M
- Employees: 73
- ImmunoPrecise is a life sciences product and technology company that engineers custom antibodies for the global research and industrial community. They use proprietary innovative inoculation and cloning technologies and established expertise to produce...
BioMarker Strategies , LLC
biomarkerstrategies.com- Founded in 2007
- Location: Rockville, MD
- Annual Revenue: $3.3M
- Employees: 13
- BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
miDiagnostics
midiagnostics.com- Founded in 2015
- Location: Leuven, Flanders
- Annual Revenue: $16.8M
- Employees: 33
- Lab quality diagnostics for everyone, anywhere, anytime. miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy to use, lab quality tests with built in connectivity direct to the patient and clinician. Combining a nan...
MeMed
me-med.com- Location: Haifa, Haifa'
- Annual Revenue: $17.7M
- Employees: 104
- MeMed has developed innovative diagnostic host immune response tests that address complex clinical dilemmas and improve patient outcomes.
Key Information
- Name: BioMark Diagnostics
- Category: Hospital & health care
- Industry: Corporate Office
- SIC: 38; 384
- NAICS: 339; 33
See similar companies
-
By City Richmond Small Corporate Office in Richmond Mid-size Corporate Office in Richmond Hospital & health care in Richmond Small Hospital & health care in Richmond Mid-size Hospital & health care in Richmond
-
By State British Columbia Small companies in British Columbia Hospital & health care in British Columbia Small Hospital & health care in British Columbia Mid-size Hospital & health care in British Columbia Small Corporate Office in British Columbia Mid-size Corporate Office in British Columbia
-
By Category Hospital & health care Small Hospital & health care Mid-size Hospital & health care
-
By Industry Corporate Office Small Corporate Office Mid-size Corporate Office Hospital & health care and Corporate Office
-
Firmographic data G Score of 6 Founded in 2014 SIC: 38 SIC: 384 NAICS: 339 NAICS: 33 #Medical Devices & Equipment #Manufacturing #Test & Measurement Equipment
Frequently Asked Questions
BioMark Diagnostics's headquarters are located at 10551 Shellbridge Way 102 Richmond, British Columbia V6X 2W8.
BioMark Diagnostics's official website is biomarkdiagnostics.com
BioMark Diagnostics's annual revenue is $15.0 K.
BioMark Diagnostics's SIC: 38; 384
BioMark Diagnostics's NAICS: 339; 33.
BioMark Diagnostics has 12 employees
BioMark Diagnostics is in the industry of Hospital & health care.
